Insider trades

Christopher Horan, Chief Officer of Artiva Biotherapeutics ARTV, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $63.1K. The latest trade was on 05/19.

Christopher Horan

Chief Tech Operations Officer
First filing
24/09/13
Trades
12 trades
Buys / sales
0 / 1
12-month net buying
−$63.1K
Last trade
05/19

Trading activity

Transactions

Trade type
Open-market sale05/1905/197,002 sh$9.01$63,088.02−2.3%